Stable salts of o-acetylsalicylic acid containing basic amino acids II

Details for Australian Patent Application No. 2003235700 (hide)

Owner Bayer Healthcare AG

Inventors Bullesbach, Ralf; Petersen-Braun, Marianne; Franckowiak, Gerhard; Gessner, Uwe; Ledwoch, Wolfram; Ecker, Felix

Agent Davies Collison Cave

Pub. Number AU-B-2003235700

PCT Number PCT/EP03/00059

PCT Pub. Number WO2003/059323

Priority 102 02 019.1 18.01.02 DE

Filing date 7 January 2003

Wipo publication date 30 July 2003

Acceptance publication date 28 June 2007

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/192 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/46 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Ingredients of undetermined constitution or reaction products thereof

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07C 69/157 (2006.01) Esters of carboxylic acids

Event Publications

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2003235700

4 September 2003 Complete Application Filed

  Priority application(s): 102 02 019.1 18.01.02 DE

28 June 2007 Application Accepted

  Published as AU-B-2003235700

25 October 2007 Standard Patent Sealed

14 May 2009 Assignment Registered

  Bayer Healthcare AG The patent has been assigned to Bayer Schering Pharma Aktiengesellschaft

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003235701-PACKING AND PRESENTATION DEVICE

2003235699-STABILIZED AQUEOUS CROSSLINKING DISPERSIONS